mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.2 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |